课题基金 / 基金详情

TO FIND THE WAY TO OVERCOME THE TUMOR ACCELERATED PROLIFERATION DURING FRACTIONATIONS OF RADIATION THERAPY

TO FIND THE WAY TO OVERCOME THE TUMOR ACCELERATED PROLIFERATION DURING FRACTIONATIONS OF RADIATION THERAPY
寻找克服放射治疗分次期间肿瘤加速增殖的方法
批准号:
11670858
负责人:
ABE Yoshinao
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

ABE Yoshinao的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The tumor repopulation (accelerated proliferation) during fractionation is thought to be a factor causing insufficient radiation effects. Using low LET irradiation and mouse jejunal crypts, we studied the mechanism of accelerated proliferation. To summarize the previous results as follows ; 1) accelerated proliferation is observed during multiple fractions of 2 Gy dose, 2) the extent of proliferation depend on the total dose per a day and 3) there are 2 possible mechanisms for accelerated proliferation-shortening of potential doubling time and reduction of cell loss factor.The purpose of this study is to clarify whether accelerated proliferation found in jejunal crypt is observed during multiple doses of high LET beams such as carbon ion beam. Carbon ion beam of LET 70 keV/μm (290 MeV/u and 6 cm SOBP) was used. Endpoint was Jejunal colony assay. After obtaining RBE, fractionation effects were compared between X-ray irradiation and carbon ion beam. Experiments were performed as follows ; 1) a single dose, 2) two split dose at an interval of 4 h and 3) fractionation for 1 to 3 days with a single top-up dose. Fraction size of carbon ion beams and X-rays are 1 Gy and 2 Gy, respectively.The results showed colony survival obtained from carbon ion beam was shifted to the sensitive side compared with that obtained from X-rays. This is either due to incomplete repair or inhibition of accelerated proliferation. The former could be ruled out, since split dose study showed repair was completed between 4 h interval. From this study, it is concluded that fractionation of carbon ion beam could inhibit, in some extent, accelerated proliferation in jejunal crypt.Some other investigations about the human cancer were also studied.This study regarding the use of carbon ion beam is performed under a Research Project with Heavy Ions at NIRS-HIMAC.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
Y.Mariya 他: "Oxygenation status and tumor response during fractionated irradiation in two murine tumor cell lines of same origin but different intrinsic radiosensitivities"Radiat Med. 17・2. 175-179 (1999)
Y.Mariya 等人:“两种来源相同但内在放射敏感性不同的小鼠肿瘤细胞系中的氧合状态和肿瘤反应”Radiat Med 175-179 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Abe, Y.Mariya and M.Aoki: "Clinical and fundamental researches of radiotherapy."Hirosaki Med J. 51. s203-207 (1999)
Y.Abe、Y.Mariya 和 M.Aoki:“放射治疗的临床和基础研究”。Hirosaki Med J. 51. s203-207 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Mariya 他: "Combined treatment effects of irradiation and SN-38, an active metabolite of camptothecin derivative irinotecan, on the human cell line PECA4197"Hirosaki Med J. 51・1. 10-14 (1999)
Y. Mariya 等:“放射线和喜树碱衍生物伊立替康的活性代谢物 SN-38 对人类细胞系 PECA4197 的组合治疗效果” Hirosaki Med J. 51·1 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Mariya 他: "Treatment outcome with T3NO-1 laryngeal carcinomas : Primary radiotherapy versus surgery with pre-/postoperative radiotherapy"Hirosaki Med J. 51・1. 38-43 (1999)
Y. Mariya 等:“T3NO-1 喉癌的治疗结果:初次放疗与术前/术后放疗的手术” Hirosaki Med J. 51・1 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
15
    Experimental study for the recovery from the radiation induced intestinall damage by transplantation of ES cells and stimulation of cytokines in mice.
    • 批准号:
      14370267
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.18万
    • 财政年份:
      2002
    • 负责人:
      ABE Yoshinao
    • 依托单位:
    COMPREHENSIVE ANALYSIS OF PROLIFERATIVE RESPONSES IN MURINE JEJUNAL CRYPT DURING MULTIPLE FRACTIONATION
    • 批准号:
      09670908
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1997
    • 负责人:
      ABE Yoshinao
    • 依托单位:
    海外基金